Dr Suruchi Vishwasrao, Sr Scientist, Merck Life Sciences

FDD Conclave 2024 | Day 1 | 19th July 2024 | Hyderabad


In this video:
Dr Suruchi Vishwasrao, Sr Scientist, Merck Life Sciences

Topic: Patient-centric dosage forms: Oro dispersible films

Key Highlights:
[1] Distinct advantage of ORO includes patient centricity due to ease of administration.

[2] Polyvinyl alcohol supports consistent final product quality and QbD, provides highly adaptable solutions and batch to batch consistency.

[3] Merck offers Parteck MXP 4-88 polymer, produced via hot melt extrusion technology that enables smooth processibility and forms homogeneous oro-dispersible films along with plasticizers.

Comments (0)
Add Comment